Assessment of disease activity and damage in SLE: Are we there yet?

被引:8
作者
Cruciani, Claudio [1 ]
Zen, Margherita [1 ]
Gatto, Mariele [2 ,3 ]
Morand, Eric [4 ]
Doria, Andrea [1 ]
机构
[1] Univ Padua, Dept Internal Med, Div Rheumatol, Azienda Osped Padova, Padua, Veneto, Italy
[2] Univ Turin, Dept Clin & Biol Sci, Rheumatol Unit, Turin, Italy
[3] Turin Mauriziano Hosp, Turin, Italy
[4] Monash Univ, Ctr Inflammatory Dis, Rheumatol Unit, Monash Hlth, Melbourne, Australia
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2023年 / 37卷 / 04期
关键词
SLE; Systemic lupus erythematosus; Disease activity index; SLEDAI; BILAG; PGA; SLE-DAS; SDI; REMISSION; Low disease activity; LLDAS; Damage; SYSTEMIC-LUPUS-ERYTHEMATOSUS; QUALITY-OF-LIFE; PHYSICIAN GLOBAL ASSESSMENT; GROUP; 2004; INDEX; ACTIVITY STATE; INITIAL VALIDATION; PROLONGED REMISSION; OUTCOME INSTRUMENT; MONOCENTRIC COHORT; CAUCASIAN PATIENTS;
D O I
10.1016/j.berh.2023.101896
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic Lupus Erythematosus is a systemic autoimmune disease characterized by a great heterogenicity in course and clinical manifestations. Although prognosis improved in the last decades of the 20th century, mortality remains higher than in the general population and uncontrolled disease activity and therapy-related adverse effects have been identified as major contributors to damage accrual and poor outcomes. Assessment of disease activity and damage in SLE represents a great challenge even to the expert rheumatologist. Global disease activity indices are tools developed to assess activity across multiple organ systems. Several disease activity indices have been developed over the years, each with its own strengths and weaknesses, and knowing them is essential for understanding research studies, such as clinical trials, in which they are used. Organ-specific activity indices have been developed concurrently to represent organ involvement such as glomerulonephritis, cutaneous and musculoskeletal lupus manifestations. Regarding damage, the SLICC/ACR damage index has proven to be an effective tool for damage accrual assessment, yet not devoid of drawbacks. This review provides an overview of the most frequently utilized indices developed for the assessment of activity and damage in SLE highlighting their pros and cons when applied to the research and clinical setting.
引用
收藏
页数:13
相关论文
共 117 条
[1]   Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS) [J].
Abdelhady, Enas, I ;
Rabie, Mona ;
Hassan, Rofaida A. .
CLINICAL RHEUMATOLOGY, 2021, 40 (11) :4553-4558
[2]   Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus - the Hopkins Lupus Cohort [J].
Al Sawah, Sarah ;
Zhang, Xiang ;
Zhu, Baojin ;
Magder, Laurence S. ;
Foster, Shonda A. ;
Iikuni, Noriko ;
Petri, Michelle .
LUPUS SCIENCE & MEDICINE, 2015, 2 (01)
[3]   Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort [J].
Alarcon, G. S. ;
Ugarte-Gil, M. F. ;
Pons-Estel, G. ;
Vila, L. M. ;
Reveille, J. D. ;
McGwin, G. .
LUPUS, 2019, 28 (03) :423-426
[4]   Systemic lupus erythematosus in three ethnic groups.: XX.: Damage as a predictor of further damage [J].
Alarcón, GS ;
Roseman, JM ;
McGwin, G ;
Uribe, A ;
Bastian, HM ;
Fessler, BJ ;
Baethge, BA ;
Friedman, AW ;
Reveille, JD .
RHEUMATOLOGY, 2004, 43 (02) :202-205
[5]   The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An outcome instrument for cutaneous lupus erythematosus [J].
Albrecht, J ;
Taylor, L ;
Berlin, JA ;
Dulay, S ;
Ang, G ;
Fakharzadeh, S ;
Kantor, J ;
Kim, E ;
Militello, G ;
McGinnis, K ;
Richardson, S ;
Treat, J ;
Vittorio, C ;
Van Voorhees, A ;
Werth, VP .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (05) :889-894
[6]   Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study [J].
Apostolopoulos, Diane ;
Kandane-Rathnayake, Rangi ;
Louthrenoo, Worawit ;
Luo, Shue Fen ;
Wu, Yeong-Jian ;
Lateef, Aisha ;
Golder, Vera ;
Sockalingam, Sargunan ;
Navarra, Sandra ;
Zamora, Leonid ;
Hamijoyo, Laniyati ;
Katsumata, Yasuhiro ;
Harigai, Masayoshi ;
Chan, Madelynn ;
O'Neill, Sean ;
Goldblatt, Fiona ;
Lau, Chak Sing ;
Li, Zhan Guo ;
Hoi, Alberta ;
Nikpour, Mandy ;
Morand, Eric .
LANCET RHEUMATOLOGY, 2020, 2 (01) :E24-E30
[7]   Independent association of glucocorticoids with damage accrual in SLE [J].
Apostolopoulos, Diane ;
Kandane-Rathnayake, Rangi ;
Raghunath, Sudha ;
Hoi, Alberta ;
Nikpour, Mandana ;
Morand, Eric F. .
LUPUS SCIENCE & MEDICINE, 2016, 3 (01)
[8]   Preliminary test of the LFA rapid evaluation of activity in lupus (LFA-REAL): an efficient outcome measure correlates with validated instruments [J].
Askanase, Anca ;
Li, Xiaoqing ;
Pong, Avery ;
Shum, Katrina ;
Kamp, Stan ;
Carthen, Fredonna ;
Aberle, Teresa ;
Hanrahan, Leslie ;
Daly, Paola ;
Giles, Jon ;
Merrill, Joan T. .
LUPUS SCIENCE & MEDICINE, 2015, 2 (01)
[9]   Definition of low disease activity state based on the SLE-DAS: derivation and validation in a multicentre real-life cohort [J].
Assuncao, Helena ;
Jesus, Diogo ;
Larosa, Maddalena ;
Henriques, Carla ;
Matos, Ana ;
Le Guern, Veronique ;
Rubino, Francisco ;
da Silva, Jose A. P. ;
Rua-Figueroa, Inigo ;
Costedoat-Chalumeau, Nathalie ;
Doria, Andrea ;
Ines, Luis S. .
RHEUMATOLOGY, 2022, 61 (08) :3309-3316
[10]   Time to Lupus Low Disease Activity State in the Hopkins Lupus Cohort: Role of African American Ethnicity [J].
Babaoglu, Hakan ;
Li, Jessica ;
Goldman, Daniel ;
Magder, Laurence S. ;
Petri, Michelle .
ARTHRITIS CARE & RESEARCH, 2020, 72 (02) :225-232